What symptomatic treatment should be started now for a patient with neuropathic pain and allodynia while awaiting skin biopsy, autonomic testing, and laboratory work‑up?

Immediate Symptomatic Treatment for Neuropathic Pain with Allodynia

Start a first-line medication immediately—either gabapentin (300 mg once daily, titrating to 1800-3600 mg/day in divided doses) or a secondary-amine tricyclic antidepressant like nortriptyline (10-25 mg at bedtime, titrating to 75-150 mg/day), and if the pain is localized, add topical lidocaine 5% patches directly to the affected area. 1

First-Line Treatment Selection

The presence of allodynia makes this patient an excellent candidate for topical lidocaine 5% patches, which have demonstrated efficacy specifically in patients with peripheral neuropathic pain and allodynia 1. This can be applied immediately to localized areas (up to 3 patches for up to 12 hours daily) with minimal systemic absorption and virtually no drug interactions—a significant advantage while you're still establishing the diagnosis 1.

Systemic First-Line Options

Choose one of the following based on patient factors:

Gabapentin or Pregabalin (Calcium Channel α2-δ Ligands):

• Gabapentin: Start 300 mg once daily, increase to 300 mg three times daily over 3-7 days, then titrate by 300 mg/day every 3-7 days up to 1800-3600 mg/day in 3 divided doses 1
• Pregabalin: Start 150 mg/day in 2-3 divided doses, increase to 300 mg/day after 1-2 weeks (may provide faster relief than gabapentin due to linear pharmacokinetics) 1
• Note: Pregabalin is Schedule V in the US and has been downgraded to second-line in recent French guidelines due to misuse concerns 2

Secondary-Amine TCAs (Nortriptyline or Desipramine):

• Start 10-25 mg at bedtime, titrate by 10-25 mg weekly to 75-150 mg/day 1
• Screen with ECG if patient >40 years old and use caution with cardiac disease or conduction abnormalities 1
• Requires 6-8 weeks for adequate trial, including 2 weeks at maximum tolerated dose 1

SSNRIs (Duloxetine or Venlafaxine):

• Alternative first-line option with fewer anticholinergic effects than TCAs 1

When to Add Tramadol or Opioids for Immediate Relief

If the patient requires prompt pain relief while titrating first-line medications, tramadol is appropriate as a bridging agent 1:

• Start 50 mg once or twice daily
• Increase by 50-100 mg/day in divided doses every 3-7 days as tolerated
• Maximum 400 mg/day (300 mg/day if >75 years old) 1
• Caution: Lowers seizure threshold and can cause serotonin syndrome when combined with SSNRIs/SSRIs 1

Critical Pitfalls to Avoid

1. Don't wait for diagnostic confirmation to start treatment—neuropathic pain management should begin immediately while testing proceeds 1

2. Allodynia specifically responds to topical lidocaine—don't overlook this safe, effective option for localized pain 1

3. Combination therapy is often necessary—if monotherapy provides only partial relief after adequate trial, add (don't switch) another first-line agent from a different class 1

4. Adequate trial duration matters: Gabapentin may require 2+ months, TCAs need 6-8 weeks, but pregabalin may work faster at 2-4 weeks 1

5. For patients with cardiac risk factors or age >40: Obtain baseline ECG before starting TCAs and limit doses to <100 mg/day when possible 1

Reassessment Timeline

Evaluate pain intensity and quality of life frequently. Target is pain ≤3/10 with tolerable side effects. If pain remains ≥4/10 after adequate trial at target dose, add a second first-line medication from a different class rather than abandoning the first 1.